Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Lorantis logo — Creating innovative solutions for targeted treatment of immu...

Lorantis

Creating innovative solutions for targeted treatment of immunological and inflammatory diseases from Cambridge, United Kingdom.

Founded 1998 Series C Total: $25.00M Health Care, Medical Devices

General Information

Company Name Lorantis
Founded Year 1998
Industries Health Care, Medical Devices
Funding Stage Series C
Social

Get notified when Lorantis moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Lorantis

Lorantis is a Health Care startup based in Cambridge, United Kingdom, with a focus on creating innovative solutions for targeting immunological and inflammatory diseases. Established in 1998, the company specializes in developing treatments for conditions such as allergies, asthma, autoimmune diseases, and transplant management. It has recently received a significant £25.00M Series C investment on 19 October 2005, with the participation of prominent investors including Abingworth, Apax Partners, Schroders, Quester Capital, Wellcome Trust, and JPMorgan Partners. Lorantis' dedication to advancing therapies in immunology positions it as a noteworthy player in the healthcare industry. With its promising solutions, the company presents an exciting opportunity for investors seeking to back pioneering initiatives in the field of targeted disease treatment.

Taxonomy: immunological diseases, inflammatory diseases, therapeutics, Cambridge, allergies, asthma, autoimmune diseases, transplant management, immunology, therapeutic advancements, treatment solutions

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 6
Investor Investor Investor Investor Investor
•••• •••• 		19 Oct 2005
Series A •••••• - 21 Jun 2000

Lorantis Alternatives & Competitors

Lorantis vs
EOM Pharmaceuticals
EOM Pharmaceuticals United States

Powering relentless science by developing and commercializing first-in-class treatments to address d...

3 employees
Health Care
Lorantis vs
Biosun Pharma
Biosun Pharma

Pioneering advancements in the treatment of tumors, self-immune, and inflammatory diseases for a hea...

Series B
Biopharma, Pharmaceutical
Lorantis vs
Pioneer Gene
Pioneer Gene

Advancing molecular diagnostics to enhance detection of genetic, tumor, and infectious diseases.

Series B
Health Care

FAQ About Lorantis

Creating innovative solutions for targeted treatment of immunological and inflammatory diseases from Cambridge, United Kingdom.
Lorantis was founded in 1998.
Lorantis operates in the following industries: Health Care, Medical Devices.
Lorantis has completed 2 funding rounds, raising a total of $25.00M. The latest funding stage is Series C.
Top alternatives and competitors to Lorantis include EOM Pharmaceuticals , Biosun Pharma, Pioneer Gene, ENYO Pharma, Antlia Bioscience, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Lorantis and EOM Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Lorantis and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy